Gossec, Laure
Coates, Laura C.
de Wit, Maarten
Kavanaugh, Arthur
Ramiro, Sofia
Mease, Philip J.
Ritchlin, Christopher T.
van der Heijde, Désirée
Smolen, Josef S.
Article History
First Online: 10 November 2016
Competing interests
: The authors declare a potential conflict of interest having received grant support and/or honoraria for consultations and/or for presentations as indicated: L.G. Abbvie, BMS, Celgene, Chugai, Janssen, MSD, Novartis, Pfizer, Roche, UCB. L.C.C. Abbvie, Amgen, Boehringer Ingelheim, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, UCB. M.d.W. BMS, Celgene, Novartis, Roche. A.K. AbbVie, Amgen, Celgene, Janssen, Novartis, UCB. S.R. no competing interests. P.M. Abbvie, Amgen, Celgene, BMS, Boehringer Ingelheim, Janssen, Lilly, Merck, Novartis, Pfizer, UCB. C.R. Abbvie, Amgen, Boehringer Ingelheim, Janssen, Lilly, Novartis, Pfizer, UCB. D.v.d.H. AbbVie, Amgen, Astellas, AstraZeneca, Augurex, BMS, Boehringer Ingelheim, Celgene, Centocor, Chugai, Covagen, Daiichi, Eli-Lilly, Galapagos, GSK, Janssen Biologics, Merck, Novartis, Novo-Nordisk, Otsuka, Pfizer, Roche, Sanofi-Aventis, UCB, Vertex. Director of Imaging Rheumatology bv. J.S.S. Abbvie, Amgen, Astra-Zeneca, Astro, BMS, Celgene, Glaxo, ILTOO, Janssen, Merck-Serono, MSD, Novartis-Sandoz, Pfizer, Roche-Chugai, Samsung, UCB.